Strength
Pharmaceutical Form Route of 
Immediate Packaging
Pack size
MA (EU) number
EU/1/15/1051/001
EU/1/15/1051/002
EU/1/15/1051/003
EU/1/15/1051/004
EU/1/15/1051/005
EU/1/15/1051/006
EU/1/15/1051/007
EU/1/15/1051/008
EU/1/15/1051/009
EU/1/15/1051/010
EU/1/15/1051/011
(Invented) 
name
Ebymect
Ebymect
Ebymect
Ebymect
Ebymect
5 mg / 850 mg
5 mg / 850 mg
5 mg / 850 mg
5 mg / 850 mg
5 mg / 850 mg
Film-coated tablet
Film-coated tablet
Film-coated tablet
Film-coated tablet
Film-coated tablet
Administration
Oral use
Oral use
Oral use
Oral use
Oral use
Ebymect
Ebymect
Ebymect
Ebymect
Ebymect
Ebymect
5 mg / 850 mg
Film-coated tablet
5 mg / 1000 mg Film-coated tablet
5 mg / 1000 mg Film-coated tablet
5 mg / 1000 mg Film-coated tablet
5 mg / 1000 mg Film-coated tablet
5 mg / 1000 mg Film-coated tablet
Oral use
Oral use
Oral use
Oral use
Oral use
Oral use
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
blister (PVC/PCTFE/Alu)
EU/1/15/1051/012
Ebymect
5 mg / 1000 mg Film-coated tablet
Oral use
blister (PVC/PCTFE/Alu)
14 tablets
28 tablets
56 tablets
60 tablets
60 x 1 tablets (unit 
dose)
196 (2 x 98) tablets
14 tablets
28 tablets
56 tablets
60 tablets
60 x 1 tablets (unit 
dose)
196 (2 x 98) tablets
Page 1/1
